GlassScriptPhysician profile
Ashley B Divers
NPI 1023407269
$1,580.38
in general payments reported to CMS, 2019-2025
25 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,088 · 2022: $12.58 · 2023: $260 · 2024: $117 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $232.41 | 2021-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $197.13 | 2021-2023 | |
| Abbvie INC. | $180.85 | 2021-2022 | |
| Cvrx, INC. | $136.13 | 2023 | Barostim Neo System |
| Abbott Laboratories | $117.48 | 2024 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.31 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $100.87 | 2021 | |
| Amgen INC. | $66.32 | 2021 | |
| Janssen Pharmaceuticals, INC | $64.90 | 2021 | |
| Amarin Pharma, INC. | $52.44 | 2021 | |
| Glaxosmithkline, LLC. | $41.30 | 2021 | |
| Esperion Therapeutics, INC. | $38.84 | 2021 | |
| Merck Sharp & Dohme LLC | $33.90 | 2021 | |
| Medtronic, INC. | $27.59 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.10 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.57 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.62 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.11 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.60 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.41 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $13.50 | 2021 | |
| Xeris Pharmaceuticals, INC. | $12.90 | 2023 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $12.70 | 2021 | |
| Astellas Pharma US INC | $11.76 | 2021 | |
| Seqirus USA INC | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Divers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.